Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tridelta Development is an Irish biotechnology company specializing in the development and manufacture of diagnostic kits for acute phase proteins. The company is a global leader in providing assays for markers such as Haptoglobin and Serum Amyloid A, which are critical for monitoring inflammation and disease in both veterinary and human research. Their "Phase" range of products includes ELISA and biochemical assays designed for high sensitivity and cross-species applicability. Tridelta's products are essential tools for veterinarians, pharmaceutical researchers, and diagnostic laboratories worldwide. The company operates from its headquarters and manufacturing facility in Maynooth, Ireland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tridelta Development.